Immunis Chairman Dr. Hans Keirstead Presents United Nations General Assembly Keynote on Behalf of the National Institute of Child Sexual Assault
IRVINE, Calif.–(BUSINESS WIRE)–#CSA–Immunis, Inc., a private biotech company generating an innovative treatment for age and disease-related immune decline, announces that its Chairman, Dr. Hans Keirstead, delivered a keynote on behalf of the National Institute of Child Sexual Assault (NICSA) at the UN General Assembly in New York City. As part of Immunis’ ongoing Corporate Social … [Read more…]
